Previous post Next post

Swiss pharma firm Novartis plans seventh US plant

Novartis is expanding its production capacity in the United States, with the announcement of a new site in Morrisville, North Carolina. This plant is the seventh site as part of the Swiss pharma's $23 billion (CHF18 million) investment plan in the US. + Get the most important news from Switzerland in your inbox The new plant will be dedicated to the production of active pharmaceutical ingredients for solid formulations (tablets, capsules) as well as for RNA-based therapies, the Basel-based pharmaceutical group said in a press release on Thursday. The 56,200-square-foot facility will bring the company's North Carolina presence to five sites in three locations. End-to-end integrated production Since committing in April 2025 to produce all of its key medicines for US patients in the US, Novartis has made significant progress in its plans to establish end-to-end integrated manufacturing. In November 2025, a dedicated manufacturing facility for radioligand therapy was opened in Carlsbad ... Full story here Are you the author?
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.
Previous post See more for 3.) Swissinfo Business and Economy Next post
Tags: ,

Permanent link to this article: https://snbchf.com/2026/04/swiss-pharma-firm-novartis-plans-seventh-plant/

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.